• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG COLLECT.NO.QAS KNEE IMPL.MISC./UNKNOWN; KNEE ENDOPROSTHETICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG COLLECT.NO.QAS KNEE IMPL.MISC./UNKNOWN; KNEE ENDOPROSTHETICS Back to Search Results
Model Number AE-QAS-K521-99
Device Problem Unstable (1667)
Patient Problems Scarring (2061); Reaction (2414)
Event Date 03/18/2020
Event Type  Injury  
Manufacturer Narrative
Manufacturing site evaluation: investigation on-going.Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that there was an issue with as enduro femoral component.The pre-operative diagnosis in (b)(6) 2019 was multi-directional instability, right knee with arthro-fibrosis, failed right total knee, loosening of tibial stem and femoral stem, and history of infection from a total knee revision.The patient was initially implanted with enduro components on (b)(6) 2019.The type of cement used in this surgery was one-on-one with tobramycin placement of pellets with 240mg of tobramycin follow by 100mg of vancomycin per mixture.There later was a failed right total knee, revision due to failure of the femoral implant with loosening but secondary to wear and debris of the carbon fiber linkage mechanism on (b)(6) 2020.The patient had been experiencing pain.Treatment included antibiotic-loaded stimulan pellets and mixture of tobramycin and vancomycin.A revision surgery was necessary.The implant that was revised was the aesculap enduro femur.A porex component from link was used as a hinge instead.It was noted that the procedure was extremely difficult which justified the use of the 22 modifier, due to the scarring and amount of wear and debris reaction.Additional information was requested.The adverse event is filed under xc (b)(4).
 
Manufacturer Narrative
Section d: leading material updated.
 
Event Description
See section d.
 
Manufacturer Narrative
Section d: leading material updated.
 
Event Description
See section d.
 
Manufacturer Narrative
Investigation: no product at hand, therefore an investigation at the devices is not possible.Batch history review: a review of the device quality and manufacturing history records is not possible because the material number as well as the batch number is unknown.Conclusion and root cause: based on the information available it is not possible to determine a definitive root cause for the failure at that time.Rationale: on the basis of the current information and without a product for investigation, a clear conclusion/root cause for the implant loosening can not be drawn.The investigation is ongoing.At that time it is not possible to verify if the black staining/debris is responsible for the implant loosening.There are many potential sources regarding to implant loosening: modification/ change in the surgical technique; cement technique; patient fall; patient allergy/infection.Corrective action: product safety case was created.
 
Event Description
No update.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COLLECT.NO.QAS KNEE IMPL.MISC./UNKNOWN
Type of Device
KNEE ENDOPROSTHETICS
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
MDR Report Key9938918
MDR Text Key187397268
Report Number2916714-2020-00084
Device Sequence Number1
Product Code KRO
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup,Followup,Followup
Report Date 07/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAE-QAS-K521-99
Device Catalogue NumberAE-QAS-K521-99
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date06/15/2020
Event Location Hospital
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/08/2020
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Supplement Dates FDA Received04/15/2020
05/04/2020
07/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age42 YR
-
-